Real-time enrollment status for this hemophilia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:31 AM UTC
| NCT Number | NCT05145127 |
| Recruiting Status | Recruiting |
| Condition | Hemophilia |
| Phase | PHASE3 |
| Target Enrollment | 245 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | July 1, 2026 (2 weeks ago) |
As of July 17, 2026: Clinical trial NCT05145127 is currently recruiting participants. This phase3 study for hemophilia is actively seeking new participants at 4 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05145127 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05145127 was last updated 2 weeks ago (July 1, 2026). HelloStudys verifies this status automatically.